Zoledronate suppressed angiogenesis and osteogenesis by inhibiting osteoclasts formation and secretion of PDGF-BB
Authors:
Open Access
- 8 June 2017
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (6) , e0179248
Abstract
Bisphosphonates related osteonecrosis of jaw (BRONJ) is a severe complication of systemic BPs administration, the mechanism of which is still unclarified. Recently, platelet-derived growth factor-BB (PDGF-BB) secreted by preosteoclasts was reported to promote angiogenesis and osteogenesis. This study aimed to clarify whether bisphosphonates suppressed preosteoclasts releasing PDGF-BB, and whether the suppression harmed coupling of angiogenesis and osteogenesis, which could contribute to BRONJ manifestation. Zoledronate significantly inhibited osteoclast formation by tartrate-resistant acid phosphatase (TRAP) staining and PDGF-BB secretion tested by ELISA. In line with decreasing secretion of PDGF-BB by preosteoclasts exposed to zoledronate, conditioned medium (CM) from the cells significantly induced less migration of endothelial progenitor cells (EPCs) and mesenchymal stem cells (MSCs) compared to CM from unexposed preosteoclasts. Meanwhile, angiogenic function of EPCs and osteoblastic differentiation of MSCs also declined when culturing with CM from preosteoclasts treated by zoledronate (PZ-CM), evidenced by tube formation assay of EPCs and alkaline phosphatase activity of MSCs. Western blot assay showed that the expression of VEGF in EPCs and OCN, RUNX2 in MSCs declined when culturing with PZ-CM compared to CM from preostoeclasts without exposure of zoledronate. Our study found that zoledronate was able to suppress preosteoclasts releasing PDGF-BB, resulting in suppression of angiogenesis and osteogenesis. Our study may partly contributed to the mechanism of BRONJ.Keywords
Funding Information
- National Natural Science Foundation of China (81172566)
- National Natural Science Foundation of China (81372884)
- National Natural Science Foundation of China (81302367)
- Guangdong Provincial Department of Science and Technology (2013B022000038)
This publication has 33 references indexed in Scilit:
- Plasma membrane calcium ATPase regulates bone mass by fine-tuning osteoclast differentiation and survivalJournal of Cell Biology, 2012
- Zoledronate Attenuates Angiogenic Effects of Angiotensin II-Stimulated Endothelial Progenitor Cells via RhoA and MAPK SignalingPLOS ONE, 2012
- Influence of Bisphosphonate Treatment on Medullary Macrophages and Osteoclasts: An Experimental StudyBone Marrow Research, 2012
- Over-Expression of PDGFR-β Promotes PDGF-Induced Proliferation, Migration, and Angiogenesis of EPCs through PI3K/Akt Signaling PathwayPLOS ONE, 2012
- Bone-bound bisphosphonate inhibits growth of adjacent non-bone cellsBone, 2011
- Bisphosphonates: The first 40yearsBone, 2011
- Molecular mechanisms and clinical applications of angiogenesisNature, 2011
- Endothelial Progenitor Cells Induce a Phenotype Shift in Differentiated Endothelial Cells towards PDGF/PDGFRβ Axis-Mediated AngiogenesisPLOS ONE, 2010
- Effects of platelet-derived growth factor, vitamin D and parathyroid hormone on osteoblasts derived from cancer patients on chronic bisphosphonate therapyInternational Journal of Molecular Medicine, 2009
- Emerging anti-cancer molecular mechanisms of aminobisphosphonatesEndocrine-Related Cancer, 2006